{
    "clinical_study": {
        "@rank": "16546", 
        "arm_group": {
            "arm_group_label": "n-acetylcysteine/placebo supplementation", 
            "arm_group_type": "Experimental", 
            "description": "n-acetylcysteine supplementation, orally in three daily dosages, at 20 mg/kg/day, daily for eight days after exercise placebo, orally in three daily dosages, content: 500 mL drink that contained water (375 mL), sugar-free cordial (125 ml), and 2 g of low-calorie glucose/dextrose powder."
        }, 
        "brief_summary": {
            "textblock": "In this investigation the investigators utilized NAC administration to foster GSH\n      availability during an 8-day period following eccentric exercise-induced muscle damage in\n      order to test our hypotheses: i) antioxidant supplementation does not disturb performance\n      and adaptations induced by exercise-induced muscle injury and ii) redox status perturbations\n      in skeletal muscle are pivotal for the regulation of muscle' inflammatory response and\n      repair."
        }, 
        "brief_title": "NAC Supplementation and Skeletal Muscle Performance", 
        "completion_date": {
            "#text": "April 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Skeletal Muscle Damage", 
            "Skeletal Muscle Performance", 
            "Intgracellular Signaling in Skeletal Muscle", 
            "Inflammatory Status"
        ], 
        "detailed_description": {
            "textblock": "The major thiol-disulfide couple of reduced (GSH) and oxidized glutathione (GSSG) is a\n      key-regulator of major transcriptional pathways regulating aseptic inflammation and recovery\n      of skeletal muscle following aseptic injury. Antioxidant supplementation may hamper\n      exercise-induced cellular adaptations.\n\n      Our objective was to examine how thiol-based antioxidant supplementation affects skeletal\n      muscle's performance and redox-sensitive signalling during the inflammatory and repair\n      phases associated with exercise-induced micro-trauma.In a double-blind, counterbalanced\n      design, 12 men received placebo (PLA) or N-acetylcysteine (NAC, 20 mg/kg/day) following\n      muscle-damaging exercise (300 eccentric contractions). In each trial, muscle performance was\n      measured at baseline, post-exercise, 2h post-exercise and daily for 8 consecutive days.\n      Muscle biopsies from vastus lateralis and blood samples were collected pre-exercise and 2h,\n      2d, and 8d post-exercise."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        a) recreationally trained as evidenced by their maximal oxygen consumption levels (VO2max\n        >45 ml/kg/min), b) were engaged in systematic exercise at least three times/week for \u226512\n        months), c) non-smokers, d) abstained from any vigorous physical activity during the\n        study,  e)abstained from consumption of caffeine, alcohol, performance-enhancing or\n        antioxidant supplements, and medications during the study.\n\n        Exclusion Criteria:\n\n        a) a known NAC intolerance or allergy, b) a recent febrile illness, c) history of muscle\n        lesion, d) lower limb trauma"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01778309", 
            "org_study_id": "NACEXERCISE2011", 
            "secondary_id": "CE-80739"
        }, 
        "intervention": {
            "arm_group_label": "n-acetylcysteine/placebo supplementation", 
            "description": "n-acetylcysteine administration: 20 mg//kg/day, orally, daily for eight days following exercise\nplacebo administration: 500 mL orally, daily for eight days following exercise", 
            "intervention_name": "n-acetylcysteine supplementation", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Exercise-induced skeletal muscle damage"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Acetylcysteine", 
                "N-monoacetylcystine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "aseptic inflammation", 
            "skeletal muscle function", 
            "exercise"
        ], 
        "lastchanged_date": "January 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Komotini", 
                    "country": "Greece", 
                    "state": "Thrace", 
                    "zip": "69100"
                }, 
                "name": "Laboratory of Physical Education & Sport Performance"
            }
        }, 
        "location_countries": {
            "country": "Greece"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effects of NAC Supplementation on Skeletal Muscle Performance Following Aseptic Injury Induced by Exercise", 
        "overall_official": {
            "affiliation": "Democritus University of Thrace, Greece", 
            "last_name": "Ioannis F Fatouros, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Greece: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Concentration of reduced glutathione in red blood cells", 
                "measure": "Change in reduced glutathione in blood", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "concentration of reduced glutathione in quadriceps skeletal muscle group", 
                "measure": "Change in reduced glutathione in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "description": "concentration of protein carbonyls", 
                "measure": "Change in protein carbonyls in red blood cells and serum", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "protein carbonyl concentration in vastus lateralis skeletal muscle", 
                "measure": "Change in protein carbonyls in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "description": "thiobarbituric acid reactive substances concentration in serum and red blood cells", 
                "measure": "Change in thiobarbituric acid reactive substances in red blood cells and serum", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "thiobarbituric acid reactive substances  concentration in vastus lateralis skeletal muscle", 
                "measure": "Change in thiobarbituric acid reactive substances in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "description": "Concentration of oxidized glutathione in red blood cells and whole blood", 
                "measure": "Change in oxidized glutathione in red blood cells and blood", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in total antioxidant capacity in serum", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "concentration of oxidized glutathione in vastus lateralis skeletal muscle", 
                "measure": "Change in oxidized glutathione in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "measure": "Change in catalase activity in red blood cells and serum", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in glutathione peroxidase activity in red blood cells", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in creatine kinase activity in plasma", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in C-reactive protein in plasma", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in macrophage infiltration in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "measure": "Change in white blood cell count in blood", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in neutrophil count in blood", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in fatty acid binding protein in plasma", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in cortisol concentration in blood", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "measure": "Change in testosterone concentration in plasma", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "Measurement of IL-1\u03b2, IL-4, IL-6, TNF-\u03b1, IL-8, IL-10, IL-12p70 concentrations in plasma", 
                "measure": "Change in cytokine concentration in plasma", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "Measurement of ICAM-1, VCAM-1, sP-selectin, sE-selectin concentrations in plasma", 
                "measure": "Change in adhesion molecule concentration in blood", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "Measurement of phosphorylation levels of protein kinase B (Akt), mammalian target of rapamycin (mTOR), serine/threonine kinase (p70S6K), ribosomal protein S6 (rpS6), nuclear factor \u03baB (NF\u03baB), serine\u2044threonine mitogen activated protein kinase (p38-MAPK) in vastus lateralis muscle.", 
                "measure": "Change in intracellular signalling proteins in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "description": "MyoD expression in vastus lateralis muscle", 
                "measure": "Change in myogenic determination factor (MyoD) protein levels in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }, 
            {
                "description": "Protein levels of TNF-\u03b1 in vastus lateralis muscle", 
                "measure": "Change in tumor necrosis factor \u03b1 in muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 2 hours post-exercise, 2 days post-exercise, 8 days post-exercise"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01778309"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Democritus University of Thrace", 
            "investigator_full_name": "Ioannis G. Fatouros", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "assessment of muscle peak and mean torque of knee extensors and flexors on an isokinetic dynamometer at 0, 90 and 180 degrees/sec", 
                "measure": "Change in muscle function of knee extensor and flexor muscle", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, 5 minutes post-exercise, 2 hours post-exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "Assessment of percent (%) lean body mass.", 
                "measure": "Body composition", 
                "safety_issue": "No", 
                "time_frame": "One day before exercise"
            }, 
            {
                "description": "Assessment of maximal oxygen consumption, an indice of cardiovascular conditioning", 
                "measure": "Maximal aerobic capacity", 
                "safety_issue": "No", 
                "time_frame": "One day before exercise"
            }, 
            {
                "description": "Assessment of dietary intake with emphasis on antioxidant element intake", 
                "measure": "Change in profile of dietary intake", 
                "safety_issue": "No", 
                "time_frame": "one hour before exercise, daily for 8 days post-exercise"
            }, 
            {
                "description": "The prevalence of potential side-effects (such as headaches or abdominal pain or any other discomfort) was monitored using a subjective 0-10 side-effects  scale on a daily bases by an unblinded investigator (for ethical reasons).", 
                "measure": "Change in side effect occurence", 
                "safety_issue": "Yes", 
                "time_frame": "one hour before exercise, daily for 8 days post-exercise"
            }
        ], 
        "source": "Democritus University of Thrace", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Democritus University of Thrace", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2010", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}